Inofab Health
A digital health platform solution for patients of Asthma, COPD or Cystic Fibrosis.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD12—18m (Dealroom.co estimates Jan 2021.)
Çankaya Ankara (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Seed | |
€1.1m | Seed | ||
N/A Valuation: €11.0m | Seed | ||
$1.5m Valuation: $16.6m | Seed | ||
$1.9m | Seed | ||
| Total Funding | AUD7.1m | ||
Related Content
Recent News about Inofab Health
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.